no statement of use filed
on 23 Oct 2023
Last Applicant/ Owned by
17383 Sunset Blvd., Suite A250
Pacific Palisades
CA
90272
Serial Number
88599810 filed on 30th Aug 2019
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design sRead More
Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research for use in pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, epilepsy, mitochondrial disease, central nervous system disease, infectious disease, and acute respiratory disease; vaccine preparations; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in in pediatric, geriatric, emergency, family, and psychiatry; pharmaceutical preparations for the treatment of infectious and hereditary diseases
No 88599810
No Service Mark
No 45455-TM1006
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 23rd Oct 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 23rd Oct 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 22nd Mar 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 21st Mar 2023 | SOU EXTENSION 5 GRANTED |
| 17th Mar 2023 | SOU TEAS EXTENSION RECEIVED |
| 17th Mar 2023 | SOU EXTENSION 5 FILED |
| 23rd Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 21st Sep 2022 | SOU TEAS EXTENSION RECEIVED |
| 21st Sep 2022 | SOU EXTENSION 4 FILED |
| 21st Sep 2022 | SOU EXTENSION 4 GRANTED |
